Histone deacetylases and their inhibition in Candida species

Frontiers in Microbiology

Volumn 7, Issue AUG, 2016, Pages

  Garnaud, Cécile ^a,b   Champleboux, Morgane ^b   Maubon, Danièle ^a,b   Cornet, Muriel ^a,b   Govin, Jérôme ^b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b UNIV GRENOBLE ALPES   (France)

Author keywords

Acetylation; Candida; Chromatin; HDAC; HDAC inhibitors

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; APICIDIN; BUTYRIC ACID; FLUCONAZOLE; FLUCYTOSINE; HEAT SHOCK PROTEIN 90; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; ITRACONAZOLE; TRICHOSTATIN A; URACIL DERIVATIVE; VALPROIC ACID; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; BIOFILM; CANDIDA; CELLULAR STRESS SIGNAL; CLINICAL TRIAL (TOPIC); DISEASE MODEL; DRUG POTENTIATION; DRUG SELECTIVITY; DRUG TARGETING; FUNGAL GENE; FUNGUS HYPHAE; GALLERIA MELLONELLA; HIGH THROUGHPUT SCREENING; HOST PATHOGEN INTERACTION; HUMAN; INVASIVE CANDIDIASIS; MULTIDRUG RESISTANCE; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PHYLOGENETIC TREE; PROTEIN FUNCTION; SHORT SURVEY;

EID: 84989196005     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.01238     Document Type: Short Survey

References (77)

1. Al-Dhaheri, R. S., and Douglas, L. J. (2010). Apoptosis in Candida biofilms exposed to amphotericin B. J. Med. Microbiol. 59, 149-157. doi: 10.1099/jmm.0.015784-0
2. Augenbraun, M., Livingston, J., Parker, R., Lederman, S., Chavoustie, S., Morgan, F., et al. (2013). "Fluconazole and MGCD290 in vulvo vaginal candidiasis (VVC): results from a randomized phase II study," in Poster 1330 in IDWeek 2013, San Francisco, CA.
3. Bitterman, K. J., Anderson, R. M., Cohen, H. Y., Latorre-Esteves, M., and Sinclair, D. A. (2002). Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J. Biol. Chem. 277, 45099-45107. doi: 10.1074/jbc. M205670200
4. Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., and White, T. C. (2012). Hidden killers: human fungal infections. Sci. Transl. Med. 4, 165rv13. doi: 10.1126/scitranslmed.3004404
5. Candido, E. P., Reeves, R., and Davie, J. R. (1978). Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 14, 105-113. doi: 10.1016/0092-8674(78)90305-7
6. Carmen, A. A., Griffin, P. R., Calaycay, J. R., Rundlett, S. E., Suka, Y., and Grunstein, M. (1999). Yeast HOS3 forms a novel trichostatin A-insensitive homodimer with intrinsic histone deacetylase activity. Proc. Natl. Acad. Sci. U.S.A. 96, 12356-12361. doi: 10.1073/pnas.96.22.12356
7. Cowen, L. E., and Lindquist, S. (2005). Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi. Science 309, 2185-2189. doi: 10.1126/science.1118370
8. De Las Peñas, A., Juárez-Cepeda, J., López-Fuentes, E., Briones-Martín-Del-Campo, M., Gutiérrez-Escobedo, G., and Castaño, I. (2015). Local and regional chromatin silencing in Candida glabrata: consequences for adhesion and the response to stress. FEMS Yeast Res. 15, fov056. doi: 10.1093/femsyr/fov056
9. Denning, D. W., and Bromley, M. J. (2015). Infectious disease. How to bolster the antifungal pipeline. Science 347, 1414-1416. doi: 10.1126/science.aaa6097
10. Domergue, R., Castaño, I., De Las Peñas, A., Zupancic, M., Lockatell, V., Hebel, J. R., et al. (2005). Nicotinic acid limitation regulates silencing of Candida adhesins during UTI. Science 308, 866-870. doi: 10.1126/science.1108640
11. Dujon, B., Sherman, D., Fischer, G., Durrens, P., Casaregola, S., Lafontaine, I., et al. (2004). Genome evolution in yeasts. Nature 430, 35-44. doi: 10.1038/nature02579
12. Enjalbert, B., Smith, D. A., Cornell, M. J., Alam, I., Nicholls, S., Brown, A. J. P., et al. (2006). Role of the Hog1 stress-activated protein kinase in the global transcriptional response to stress in the fungal pathogen Candida albicans. Mol. Biol. Cell 17, 1018-1032. doi: 10.1091/mbc. E05-06-0501
13. Falkenberg, K. J., and Johnstone, R. W. (2014). Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat. Rev. Drug Discov. 13, 673-691. doi: 10.1038/nrd4360
14. Freire-Benéitez, V., Price, R. J., Tarrant, D., Berman, J., and Buscaino, A. (2016). Candida albicans repetitive elements display epigenetic diversity and plasticity. Sci. Rep. 6, 22989. doi: 10.1038/srep22989
15. Froyd, C. A., Kapoor, S., Dietrich, F., and Rusche, L. N. (2013). The deacetylase Sir2 from the yeast Clavispora lusitaniae lacks the evolutionarily conserved capacity to generate subtelomeric heterochromatin. PLoS Genet. 9:e1003935. doi: 10.1371/journal.pgen.1003935
16. Fu, X.-H., Meng, F.-L., Hu, Y., and Zhou, J.-Q. (2008). Candida albicans, a distinctive fungal model for cellular aging study. Aging Cell 7, 746-757. doi: 10.1111/j.1474-9726.2008.00424.x
17. Fuchs, B. B., and Mylonakis, E. (2009). Our paths might cross: the role of the fungal cell wall integrity pathway in stress response and cross talk with other stress response pathways. Eukaryot. Cell 8, 1616-1625. doi: 10.1128/EC.00193-09
18. Göttlicher, M., Minucci, S., Zhu, P., Krämer, O. H., Schimpf, A., Giavara, S., et al. (2001). Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 20, 6969-6978. doi: 10.1093/emboj/20.24.6969
19. Gow, N. A. R., van de Veerdonk, F. L., Brown, A. J. P., and Netea, M. G. (2012). Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat. Rev. Microbiol. 10, 112-122. doi: 10.1038/nrmicro2711
20. Hernday, A. D., Lohse, M. B., Fordyce, P. M., Nobile, C. J., DeRisi, J. L., and Johnson, A. D. (2013). Structure of the transcriptional network controlling white-opaque switching in Candida albicans. Mol. Microbiol. 90, 22-35. doi: 10.1111/mmi.12329
21. Hnisz, D., Bardet, A. F., Nobile, C. J., Petryshyn, A., Glaser, W., Schöck, U., et al. (2012). A histone deacetylase adjusts transcription kinetics at coding sequences during Candida albicans morphogenesis. PLoS Genet. 8:e1003118. doi: 10.1371/journal.pgen.1003118
22. Hnisz, D., Majer, O., Frohner, I. E., Komnenovic, V., and Kuchler, K. (2010). The Set3/Hos2 histone deacetylase complex attenuates cAMP/PKA signaling to regulate morphogenesis and virulence of Candida albicans. PLoS Pathog. 6:e1000889. doi: 10.1371/journal.ppat.1000889
23. Hnisz, D., Schwarzmüller, T., and Kuchler, K. (2009). Transcriptional loops meet chromatin: a dual-layer network controls white-opaque switching in Candida albicans. Mol. Microbiol. 74, 1-15. doi: 10.1111/j.1365-2958.2009.06772.x
24. Kapoor, S., Zhu, L., Froyd, C., Liu, T., and Rusche, L. N. (2015). Regional centromeres in the yeast Candida lusitaniae lack pericentromeric heterochromatin. Proc. Natl. Acad. Sci. U.S.A. 112, 12139-12144. doi: 10.1073/pnas.1508749112
25. Karthikeyan, G., Paul-Satyaseela, M., Dhatchana Moorthy, N., Gopalaswamy, R., and Narayanan, S. (2013). Functional characterization of Candida albicans Hos2 histone deacetylase. F1000Res. 2, 238. doi: 10.12688/f1000research.2-238.v3
26. Kim, J., Lee, J.-E., and Lee, J.-S. (2015). Histone deacetylase-mediated morphological transition in Candida albicans. J. Microbiol. 53, 805-811. doi: 10.1007/s12275-015-5488-3
27. Kim, T., Xu, Z., Clauder-Münster, S., Steinmetz, L. M., and Buratowski, S. (2012). Set3 HDAC mediates effects of overlapping noncoding transcription on gene induction kinetics. Cell 150, 1158-1169. doi: 10.1016/j.cell.2012.08.016
28. Klar, A. J., Srikantha, T., and Soll, D. R. (2001). A histone deacetylation inhibitor and mutant promote colony-type switching of the human pathogen Candida albicans. Genetics 158, 919-924.
29. Kvaal, C. A., Srikantha, T., and Soll, D. R. (1997). Misexpression of the white-phase-specific gene WH11 in the opaque phase of Candida albicans affects switching and virulence. Infect. Immun. 65, 4468-4475.
30. Landry, J., Sutton, A., Tafrov, S. T., Heller, R. C., Stebbins, J., Pillus, L., et al. (2000). The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc. Natl. Acad. Sci. U.S.A. 97, 5807-5811. doi: 10.1073/pnas.110148297
31. Lee, J.-E., Oh, J.-H., Ku, M., Kim, J., Lee, J.-S., and Kang, S.-O. (2015). Ssn6 has dual roles in Candida albicans filament development through the interaction with Rpd31. FEBS Lett. 589, 513-520. doi: 10.1016/j.febslet.2015.01.011
32. Li, X., Cai, Q., Mei, H., Zhou, X., Shen, Y., Li, D., et al. (2015). The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in Candida albicans. J. Antimicrob. Chemother. 70, 1993-2003. doi: 10.1093/jac/dkv070
33. Lionakis, M. S. (2011). Drosophila and Galleria insect model hosts. Virulence 2, 521-527. doi: 10.4161/viru.2.6.18520
34. Liu, T. T., Lee, R. E. B., Barker, K. S., Lee, R. E., Wei, L., Homayouni, R., et al. (2005). Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob. Agents Chemother. 49, 2226-2236. doi: 10.1128/AAC.49.6.2226-2236.2005
35. Lombardi, P. M., Cole, K. E., Dowling, D. P., and Christianson, D. W. (2011). Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes. Curr. Opin. Struct. Biol. 21, 735-743. doi: 10.1016/j.sbi.2011.08.004
36. Lu, Y., Su, C., and Liu, H. (2012). A GATA transcription factor recruits Hda1 in response to reduced Tor1 signaling to establish a hyphal chromatin state in Candida albicans. PLoS Pathog. 8:e1002663. doi: 10.1371/journal.ppat.1002663
37. Lu, Y., Su, C., Wang, A., and Liu, H. (2011). Hyphal development in Candida albicans requires two temporally linked changes in promoter chromatin for initiation and maintenance. PLoS Biol. 9:e1001105. doi: 10.1371/journal.pbio.1001105
38. Maglott, D., Ostell, J., Pruitt, K. D., and Tatusova, T. (2007). Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res. 35, D26-D31. doi: 10.1093/nar/gkl993
39. Mai, A., Rotili, D., Massa, S., Brosch, G., Simonetti, G., Passariello, C., et al. (2007). Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans. Bioorg. Med. Chem. Lett. 17, 1221-1225. doi: 10.1016/j.bmcl.2006.12.028
40. Maubon, D., Garnaud, C., Calandra, T., Sanglard, D., and Cornet, M. (2014). Resistance of Candida spp. to antifungal drugs in the ICU: where are we now? Intensive Care Med. 40, 1241-1255. doi: 10.1007/s00134-014-3404-7
41. Morschhäuser, J. (2010). Regulation of multidrug resistance in pathogenic fungi. Fungal Genet. Biol. 47, 94-106. doi: 10.1016/j.fgb.2009.08.002
42. Mottamal, M., Zheng, S., Huang, T. L., and Wang, G. (2015). Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents. Mol. Basel Switz. 20, 3898-3941. doi: 10.3390/molecules20033898
43. Nobile, C. J., Fox, E. P., Hartooni, N., Mitchell, K. F., Hnisz, D., Andes, D. R., et al. (2014). A histone deacetylase complex mediates biofilm dispersal and drug resistance in Candida albicans. mBio 5, e01201-e1214. doi: 10.1128/mBio.01201-14
44. Nobile, C. J., Fox, E. P., Nett, J. E., Sorrells, T. R., Mitrovich, Q. M., Hernday, A. D., et al. (2012). A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 148, 126-138. doi: 10.1016/j.cell.2011.10.048
45. Orta-Zavalza, E., Guerrero-Serrano, G., Gutiérrez-Escobedo, G., Cañas-Villamar, I., Juárez-Cepeda, J., Castaño, I., et al. (2013). Local silencing controls the oxidative stress response and the multidrug resistance in Candida glabrata. Mol. Microbiol. 88, 1135-1148. doi: 10.1111/mmi.12247
46. Pérez-Martín, J., Uría, J. A., and Johnson, A. D. (1999). Phenotypic switching in Candida albicans is controlled by a SIR2 gene. EMBO J. 18, 2580-2592. doi: 10.1093/emboj/18.9.2580
47. Perlin, D. S., Shor, E., and Zhao, Y. (2015). Update on antifungal drug resistance. Curr. Clin. Microbiol. Rep. 2, 84-95. doi: 10.1007/s40588-015-0015-1
48. Pfaller, M. A., Messer, S. A., Georgopapadakou, N., Martell, L. A., Besterman, J. M., and Diekema, D. J. (2009). Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens. J. Clin. Microbiol. 47, 3797-3804. doi: 10.1128/JCM.00618-09
49. Pfaller, M. A., Rhomberg, P. R., Messer, S. A., and Castanheira, M. (2015). In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species. Diagn. Microbiol. Infect. Dis. 81, 259-263. doi: 10.1016/j.diagmicrobio.2014.11.008
50. Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., and Klein, P. S. (2001). Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276, 36734-36741. doi: 10.1074/jbc. M101287200
51. Polke, M., Hube, B., and Jacobsen, I. D. (2015). Candida survival strategies. Adv. Appl. Microbiol. 91, 139-235. doi: 10.1016/bs.aambs.2014.12.002
52. Rai, M. N., Balusu, S., Gorityala, N., Dandu, L., and Kaur, R. (2012). Functional genomic analysis of Candida glabrata-macrophage interaction: role of chromatin remodeling in virulence. PLoS Pathog. 8:e1002863. doi: 10.1371/journal.ppat.1002863
53. Rajasekharan, S. K., Ramesh, S., and Bakkiyaraj, D. (2015). Synergy of flavonoids with HDAC inhibitor: new approach to target Candida tropicalis biofilms. J. Chemother. 27, 246-249. doi: 10.1179/1973947814Y.0000000186
54. Robbins, N., Leach, M. D., and Cowen, L. E. (2012). Lysine deacetylases Hda1 and Rpd3 regulate Hsp90 function thereby governing fungal drug resistance. Cell Rep. 2, 878-888. doi: 10.1016/j.celrep.2012.08.035
55. Roger, T., Lugrin, J., Le Roy, D., Goy, G., Mombelli, M., Koessler, T., et al. (2011). Histone deacetylase inhibitors impair innate immune responses to toll-like receptor agonists and to infection. Blood 117, 1205-1217. doi: 10.1182/blood-2010-05-284711
56. Rundlett, S. E., Carmen, A. A., Kobayashi, R., Bavykin, S., Turner, B. M., and Grunstein, M. (1996). HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription. Proc. Natl. Acad. Sci. U.S.A. 93, 14503-14508. doi: 10.1073/pnas.93.25.14503
57. Sanders, B. D., Zhao, K., Slama, J. T., and Marmorstein, R. (2007). Structural basis for nicotinamide inhibition and base exchange in Sir2 enzymes. Mol. Cell 25, 463-472. doi: 10.1016/j.molcel.2006.12.022
58. Shor, E., and Perlin, D. S. (2015). Coping with stress and the emergence of multidrug resistance in fungi. PLoS Pathog. 11:e1004668. doi: 10.1371/journal.ppat.1004668
59. Simonetti, G., Passariello, C., Rotili, D., Mai, A., Garaci, E., and Palamara, A. T. (2007). Histone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans. FEMS Yeast Res. 7, 1371-1380. doi: 10.1111/j.1567-1364.2007.00276.x
60. Singh, R. P., Prasad, H. K., Sinha, I., Agarwal, N., and Natarajan, K. (2011). Cap2-HAP complex is a critical transcriptional regulator that has dual but contrasting roles in regulation of iron homeostasis in Candida albicans. J. Biol. Chem. 286, 25154-25170. doi: 10.1074/jbc. M111.233569
61. Smith, W. L., and Edlind, T. D. (2002). Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation. Antimicrob. Agents Chemother. 46, 3532-3539. doi: 10.1128/AAC.46.11.3532-3539.2002
62. Somoza, J. R., Skene, R. J., Katz, B. A., Mol, C., Ho, J. D., Jennings, A. J., et al. (2004). Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. Structure 12, 1325-1334. doi: 10.1016/j.str.2004.04.012
63. Srikantha, T., Tsai, L., Daniels, K., Klar, A. J., and Soll, D. R. (2001). The histone deacetylase genes HDA1 and RPD3 play distinct roles in regulation of high-frequency phenotypic switching in Candida albicans. J. Bacteriol. 183, 4614-4625. doi: 10.1128/JB.183.15.4614-4625.2001
64. Stevenson, J. S., and Liu, H. (2011). Regulation of white and opaque cell-type formation in Candida albicans by Rtt109 and Hst3. Mol. Microbiol. 81, 1078-1091. doi: 10.1111/j.1365-2958.2011.07754.x
65. Stevenson, J. S., and Liu, H. (2013). Nucleosome assembly factors CAF-1 and HIR modulate epigenetic switching frequencies in an H3K56 acetylation-associated manner in Candida albicans. Eukaryot. Cell 12, 591-603. doi: 10.1128/EC.00334-12
66. Sudbery, P. E. (2011). Growth of Candida albicans hyphae. Nat. Rev. Microbiol. 9, 737-748. doi: 10.1038/nrmicro2636
67. Taff, H. T., Mitchell, K. F., Edward, J. A., and Andes, D. R. (2013). Mechanisms of Candida biofilm drug resistance. Future Microbiol. 8, 1325-1337. doi: 10.2217/fmb.13.101
68. Trojer, P., Brandtner, E. M., Brosch, G., Loidl, P., Galehr, J., Linzmaier, R., et al. (2003). Histone deacetylases in fungi: novel members, new facts. Nucleic Acids Res. 31, 3971-3981. doi: 10.1093/nar/gkg473
69. Tscherner, M., Zwolanek, F., Jenull, S., Sedlazeck, F. J., Petryshyn, A., Frohner, I. E., et al. (2015). The Candida albicans histone acetyltransferase Hat1 regulates stress resistance and virulence via distinct chromatin assembly pathways. PLoS Pathog. 11:e1005218. doi: 10.1371/journal.ppat.1005218
70. Tsuji, N., Kobayashi, M., Nagashima, K., Wakisaka, Y., and Koizumi, K. (1976). A new antifungal antibiotic, trichostatin. J. Antibiot. 29, 1-6. doi: 10.7164/antibiotics.29.1
71. Uhl, M. A., Biery, M., Craig, N., and Johnson, A. D. (2003). Haploinsufficiency-based large-scale forward genetic analysis of filamentous growth in the diploid human fungal pathogen C.albicans. EMBO J. 22, 2668-2678. doi: 10.1093/emboj/cdg256
72. Uppuluri, P., Pierce, C. G., Thomas, D. P., Bubeck, S. S., Saville, S. P., and Lopez-Ribot, J. L. (2010). The transcriptional regulator Nrg1p controls Candida albicans biofilm formation and dispersion. Eukaryot. Cell 9, 1531-1537. doi: 10.1128/EC.00111-10
73. Wurtele, H., Tsao, S., Lépine, G., Mullick, A., Tremblay, J., Drogaris, P., et al. (2010). Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy. Nat. Med. 16, 774-780. doi: 10.1038/nm.2175
74. Yoshida, M., Kijima, M., Akita, M., and Beppu, T. (1990). Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265, 17174-17179.
75. Yoshida, M., Nomura, S., and Beppu, T. (1987). Effects of trichostatins on differentiation of murine erythroleukemia cells. Cancer Res. 47, 3688-3691.
76. Zacchi, L. F., Schulz, W. L., and Davis, D. A. (2010). HOS2 and HDA1 encode histone deacetylases with opposing roles in Candida albicans morphogenesis. PLoS ONE 5:e12171. doi: 10.1371/journal.pone.0012171
77. Zhang, L., and Xu, W. (2015). Histone deacetylase inhibitors for enhancing activity of antifungal agent: a patent evaluation of WO2014041424(A1). Expert Opin. Ther. Pat. 25, 237-240. doi: 10.1517/13543776.2014.981256